Dow Jones

40 211,72

0,53%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:TEVA

<< Précédent 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
01/06/2017	09h02	Dow Jones News	Opioid Makers Sued for Stoking Addiction -- WSJ	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/06/2017	03h58	Dow Jones News	Ohio Sues Five Drug Firms, Saying They Fueled Opioid Crisis -- 2nd Update	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
31/05/2017	23h16	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
31/05/2017	21h12	Dow Jones News	Ohio Sues Five Drug Firms, Saying They Fueled Opioid Crisis -- Update	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
31/05/2017	14h32	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
31/05/2017	14h22	Business Wire	Teva Announces Positive Results for Phase III Study of Fremanezumab for the Prevention of Chronic Migraine	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
17/05/2017	15h00	Business Wire	Teva Showcases Asthma Research at the 2017 American Thoracic Society (ATS) International Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
17/05/2017	14h00	Business Wire	Teva to Present Data for Deutetrabenazine in Tardive Dyskinesia at the American Psychiatric Association 2017 Annual Meeting	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
15/05/2017	19h20	Business Wire	Teva Announces Launch of Generic Glumetza® in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
15/05/2017	14h00	Business Wire	Otsuka and Teva Sign Licensing Agreement for Japan on Prophylactic Migraine Drug Candidate Fremanezumab (TEV-48125)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
11/05/2017	13h00	Business Wire	Teva Reports First Quarter 2017 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
09/05/2017	17h52	Dow Jones News	Thin Is In as Allergan Dodges Generics Bullet -- Heard on the Street	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
05/05/2017	20h00	Business Wire	Teva and Active Biotech Announce CONCERTO trial of Laquinimod in RRMS Did Not Meet Primary Endpoint	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
05/05/2017	14h00	Business Wire	Teva Announces Publication of COPAXONE® (glatiramer acetate injection) Pregnancy Data in the International Journal of MS Care	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/05/2017	05h27	Dow Jones News	Perrigo Says Investigators Searched Its Offices in Generic-Drug Probe	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/04/2017	14h00	Business Wire	Teva Announces Publication of ARM-TD Study Results in Neurology® for the Investigational Use of Deutetrabenazine in Tardive ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
26/04/2017	22h09	Business Wire	Teva Announces Launch of Generic Vytorin® in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
26/04/2017	15h02	Business Wire	Teva Announces Planned Departure of Eyal Desheh, Group Executive Vice President and Chief Financial Officer	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
20/04/2017	14h42	Business Wire	Teva Launches AirDuo™ RespiClick® and its Authorized Generic, Two Inhalers Containing Fluticasone Propionate and Salmeterol	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
19/04/2017	14h00	Business Wire	Teva Showcases CNS Portfolio at 69th Annual Meeting of the American Academy of Neurology	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
06/04/2017	14h30	Business Wire	Teva to Report First Quarter 2017 Financial Results on May 11, 2017	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/04/2017	14h32	Business Wire	Teva erzielt positives Ergebnis für Etikett von dreimal wöchentlichem COPAXONE® 40 mg/ml in Europa	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/04/2017	13h08	Business Wire	Teva obtient une issue positive pour l’étiquetage de COPAXONE® 40 mg/ml 3 fois par semaine en Europe	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/04/2017	08h00	Business Wire	Teva Receives Positive Outcome for COPAXONE® 40 mg/ml 3 Times Weekly Label in Europe	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
16/03/2017	18h58	Business Wire	Teva Announces Launch of Authorized Generic of Minastrin® 24 Fe (norethindrone acetate & ethinyl estradiol tablets & ferrous...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
13/03/2017	16h00	Business Wire	Teva to Present at the Barclays Global Annual Healthcare Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
06/03/2017	16h56	Business Wire	Teva to Present at the Cowen & Company 37th Annual Healthcare Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/03/2017	16h56	Business Wire	Teva Announces Launch of Generic Pristiq® in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/02/2017	14h00	Business Wire	Teva Announces Priority Review Granted by FDA for SD-809 for Treatment of Tardive Dyskinesia	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
16/02/2017	00h10	Business Wire	Teva Files 2016 Annual Report on Form 20-F	NYSE:TEVA	Teva Pharmaceutical Industries Ltd